State Street’s Fortress Biotech FBIO Stock Holding History

State Street’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$283K	Buy	101,601 +24,335	+31%	+$82.7K	﹤0.01%	3803
2025 Q4	$283K	Buy	77,266 +8,000	+12%	+$22.8K	﹤0.01%	3814
2025 Q3	$256K	Buy	69,266 +25,300	+58%	+$64K	﹤0.01%	3834
2025 Q2	$81.8K	Hold	43,966	–	–	﹤0.01%	4013
2025 Q1	$68.6K	Hold	43,966	–	–	﹤0.01%	4043
2024 Q4	$89K	Buy	43,966 +18,000	+69%	+$32.6K	﹤0.01%	4012
2024 Q3	$37.5K	Hold	25,966	–	–	﹤0.01%	4141
2024 Q2	$44.4K	Buy	25,966 +7,500	+41%	+$13.6K	﹤0.01%	4164
2024 Q1	$36.9K	Hold	18,466	–	–	﹤0.01%	4206
2023 Q4	$55.6K	Sell	18,466 -2	-0%	-$5	﹤0.01%	4179
2023 Q3	$80.4K	Sell	18,468 -617	-3%	-$4.23K	﹤0.01%	4164
2023 Q2	$157K	Sell	19,085 -887	-4%	-$8.77K	﹤0.01%	4077
2023 Q1	$246K	Hold	19,972	–	–	﹤0.01%	3995
2022 Q4	$196K	Sell	19,972 -1,120	-5%	-$12.4K	﹤0.01%	4105
2022 Q3	$272K	Hold	21,092	–	–	﹤0.01%	4006
2022 Q2	$266K	Sell	21,092 -65,106	-76%	-$965K	﹤0.01%	4085
2022 Q1	$1.76M	Buy	86,198 +3,291	+4%	+$90.1K	﹤0.01%	3616
2021 Q4	$3.11M	Sell	82,907 -52	-0.1%	-$2.32K	﹤0.01%	3473
2021 Q3	$4.01M	Sell	82,959 -255	-0.3%	-$12.4K	﹤0.01%	3346
2021 Q2	$4.46M	Buy	83,214 +9,429	+13%	+$569K	﹤0.01%	3302
2021 Q1	$3.91M	Sell	73,785 -3,635	-5%	-$205K	﹤0.01%	3159
2020 Q4	$3.68M	Sell	77,420 -152	-0.2%	-$6.58K	﹤0.01%	3114
2020 Q3	$4.7M	Buy	77,572 +17,874	+30%	+$910K	﹤0.01%	2816
2020 Q2	$2.4M	Buy	59,698 +55,930	+1,484%	+$2.08M	﹤0.01%	3107
2020 Q1	$107K	Hold	3,768	–	–	﹤0.01%	3613
2019 Q4	$145K	Sell	3,768 -1,332	-26%	-$34.2K	﹤0.01%	3662
2019 Q3	$108K	Sell	5,100 -962	-16%	-$22.6K	﹤0.01%	3662
2019 Q2	$136K	Sell	6,062 -31,987	-84%	-$823K	﹤0.01%	3642
2019 Q1	$1.02M	Buy	38,049 +1,084	+3%	+$28.4K	﹤0.01%	3336
2018 Q4	$477K	Buy	36,965 +1,770	+5%	+$29.6K	﹤0.01%	3454
2018 Q3	$844K	Buy	35,195 +1,118	+3%	+$35.8K	﹤0.01%	3427
2018 Q2	$1.52M	Buy	34,077 +726	+2%	+$40.9K	﹤0.01%	3344
2018 Q1	$2.27M	Buy	33,351 +1,161	+4%	+$73.5K	﹤0.01%	3121
2017 Q4	$1.93M	Buy	32,190 +1,091	+4%	+$64.3K	﹤0.01%	3195
2017 Q3	$2.06M	Sell	31,099 -82	-0.3%	-$5.53K	﹤0.01%	3192
2017 Q2	$2.22M	Buy	31,181 +4,008	+15%	+$237K	﹤0.01%	3090
2017 Q1	$1.51M	Buy	27,173 +4,480	+20%	+$200K	﹤0.01%	3184
2016 Q4	$919K	Buy	22,693 +2,844	+14%	+$106K	﹤0.01%	3294
2016 Q3	$883K	Buy	19,849 +1,940	+11%	+$82.5K	﹤0.01%	3216
2016 Q2	$723K	Buy	17,909 +17,120	+2,170%	+$797K	﹤0.01%	3338
2016 Q1	$37K	Hold	789	–	–	﹤0.01%	3633
2015 Q4	$33K	Hold	789	–	–	﹤0.01%	3626
2015 Q3	$31K	Hold	789	–	–	﹤0.01%	3619
2015 Q2	$40K	Hold	789	–	–	﹤0.01%	3612
2015 Q1	$45K	Hold	789	–	–	﹤0.01%	3590
2014 Q4	$28K	Sell	789 -86	-10%	-$2.53K	﹤0.01%	3630
2014 Q3	$28K	Hold	875	–	–	﹤0.01%	3622
2014 Q2	$22K	Sell	875 -20,513	-96%	-$541K	﹤0.01%	3600
2014 Q1	$634K	Buy	21,388 +528	+3%	+$20.6K	﹤0.01%	3331
2013 Q4	$822K	Buy	20,860 +1,816	+10%	+$70.1K	﹤0.01%	3279
2013 Q3	$2M	Buy	19,044 +1,092	+6%	+$134K	﹤0.01%	3039
2013 Q2	$2.31M	Buy	+17,952	New	+$2.65M	﹤0.01%	2905

Other funds holding FBIO

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street's FBIO Position: Q1 2026 in Review

State Street increased its Fortress Biotech (FBIO) stake by 31% in Q1 2026, buying an estimated $82.7K and bringing the position to 101,601 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #3803.

State Street first reported a position in FBIO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.7M in Q3 2020. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

State Street held 101,601 shares of Fortress Biotech worth $283K as of Q1 2026.
State Street bought 24,335 Fortress Biotech shares in Q1 2026, an estimated $82.7K.
Fortress Biotech made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3803 holding.
State Street first reported a position in Fortress Biotech in Q2 2013 and has held it in 52 quarters since.
State Street's Fortress Biotech position peaked at $4.7M in Q3 2020.
51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.